-
1 . Academic Journal
Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136)
- 저자
- by Yeni, P; LaMarca, A; Berger, D; Cimoch, P; Lazzarin, A, et al.
- 소스
- HIV Medicine. Feb 01, 2009 10(2):116-124